stocks logo

CCAP

Crescent Capital BDC Inc
$
14.760
-0.24(-1.600%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
15.160
Open
15.160
VWAP
14.88
Vol
278.05K
Mkt Cap
547.03M
Low
14.740
Amount
4.14M
EV/EBITDA(TTM)
12.80
Total Shares
37.06M
EV
1.45B
EV/OCF(TTM)
--
P/S(TTM)
3.56
Crescent Capital BDC, Inc. is a specialty finance company focused on lending to middle-market companies. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It invests primarily in secured debt, including first lien, unitranche first lien and second-lien debt, and unsecured debt, including mezzanine and subordinated debt, as well as related equity securities of private United States middle-market companies. It is focused on purchasing interests in loans or making debt investments, either directly from its target companies as primary market or private credit investments (private credit transactions), or primary or secondary market bank loans or high-yield transactions in the syndicated market (syndicated loans and bonds). Although its focus is on investing in less liquid private credit transactions. The Company is managed by Crescent Cap Advisors, LLC.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q1
FY2024Q4
42.52M
-13.14%
0.467
-20.9%
45.08M
-10.48%
0.525
-16.67%
47.27M
-5.39%
0.560
-8.2%
Estimates Revision
The market is revising No Change the revenue expectations for Crescent Capital BDC, Inc. (CCAP) for FY2024, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -7.63%.
Revenue Estimates for FY2024
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2024
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-7.63%
In Past 3 Month
5 Analyst Rating
up Image
16.53% Upside
Wall Street analysts forecast CCAP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CCAP is 17.20 USD with a low forecast of 15.00 USD and a high forecast of 20.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
up Image
16.53% Upside
Current: 14.760
sliders
Low
15.00
Averages
17.20
High
20.00
Keefe Bruyette
Market Perform -> Outperform
upgrade
$17
2025-07-23
New
Reason
Keefe Bruyette upgraded Crescent Capital BDC to Outperform from Market Perform with a $17 price target. Keefe expects a stable quarter for business development company earnings results, with fewer headwinds from rates and spreads, and activity slowed, but exited the quarter at a good pace and could set up a stronger second half, the analyst tells investors in a research note.
Keefe Bruyette
Keefe Bruyette
Market Perform -> Outperform
upgrade
$17
2025-07-22
New
Reason
Keefe Bruyette upgraded Crescent Capital BDC to Outperform from Market Perform with an unchanged price target of $17.
BofA
Buy
downgrade
$20 -> $17
2025-06-01
Reason
Keefe Bruyette
Outperform -> Market Perform
downgrade
$17
2025-05-16
Reason
Keefe Bruyette downgraded Crescent Capital BDC to Market Perform from Outperform with a price target of $17, down from $18.50. The company's earnings missed this quarter and it will be difficult for the shares to trade significantly higher if its credit quality is not holding up, the analyst tells investors in a research note. The firm cites some recent credit issues and an operating return on equity that is now at the lower end of the sector for the downgrade.
Wells Fargo
Finian O'Shea
Equal Weight
downgrade
$16 -> $15
2025-05-16
Reason
Wells Fargo analyst Finian O'Shea lowered the firm's price target on Crescent Capital BDC to $15 from $16 and keeps an Equal Weight rating on the shares. The firm says that Falling base rates are likely a strong headwind to Crescent Capital BDC given its tighter net interest margin profile.
Raymond James
Outperform
to
NULL
downgrade
$20 -> $17
2025-05-16
Reason
Raymond James lowered the firm's price target on Crescent Capital BDC to $17 from $20 and keeps an Outperform rating on the shares. While fourth quarter results were well below the firm's estimates, Raymond James continues to see an attractive risk/reward, with a conservatively implemented variable dividend policy, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Crescent Capital BDC Inc (CCAP.O) is 6.57, compared to its 5-year average forward P/E of 8.49. For a more detailed relative valuation and DCF analysis to assess Crescent Capital BDC Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
8.49
Current PE
6.57
Overvalued PE
10.12
Undervalued PE
6.86

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
3.97
Current PS
2.92
Overvalued PS
4.92
Undervalued PS
3.02

Financials

Annual
Quarterly
FY2025Q1
YoY :
-46.57%
29.41M
Total Revenue
FY2025Q1
YoY :
-56.70%
19.04M
Operating Profit
FY2025Q1
YoY :
-86.06%
3.90M
Net Income after Tax
FY2025Q1
YoY :
-85.53%
0.11
EPS - Diluted
FY2025Q1
YoY :
-5.19%
85.54
Gross Profit Margin - %
FY2025Q1
YoY :
-73.91%
13.27
Net Margin - %
FY2025Q1
YoY :
-35.00%
6.76
ROIC

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
3.8M
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

CCAP News & Events

Events Timeline

2025-05-14 (ET)
2025-05-14
16:47:52
Crescent Capital BDC reports Q1 EPS 45c, consensus 52c
select
2025-02-19 (ET)
2025-02-19
17:00:23
Crescent Capital BDC reports Q4 EPS 55c, consensus 56c
select
2024-11-12 (ET)
2024-11-12
05:20:01
Crescent Capital BDC reports Q3 EPS 64c, consensus 57c
select
Sign Up For More Events

News

8.0
07-16TipRanks
3 Stocks with the Highest Dividends Today, 7/16/25
8.0
06-29TipRanks
Ex-Dividend Date Nearing for These 10 Stocks – Week of June 30, 2025
8.0
06-13NASDAQ.COM
Generate Yields up to 13% For as Little as $8 (No Microcaps, No Options)
Sign Up For More News

FAQ

arrow icon

What is Crescent Capital BDC Inc (CCAP) stock price today?

The current price of CCAP is 14.76 USD — it has decreased -1.6 % in the last trading day.

arrow icon

What is Crescent Capital BDC Inc (CCAP)'s business?

arrow icon

What is the price predicton of CCAP Stock?

arrow icon

What is Crescent Capital BDC Inc (CCAP)'s revenue for the last quarter?

arrow icon

What is Crescent Capital BDC Inc (CCAP)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for Crescent Capital BDC Inc (CCAP)'s fundamentals?

arrow icon

How many employees does Crescent Capital BDC Inc (CCAP). have?

arrow icon

What is Crescent Capital BDC Inc (CCAP) market cap?